New Products

SILVER SPRING, Md. — The Food and Drug Administration has approved a treatment for a rare bleeding disorder.

The FDA announced the approval of Corifact, used to prevent bleeding in people with the genetic disorder congenital Factor XIII deficiency, which affects 1-in-3 million to 5 million people in the United States.

The drug is manufactured by Marburg, Germany-based CSL Behring.

NEW YORK — TeleBrands, a developer of "As Seen On TV" products, has introduced three new innovations.

The lineup includes:

• Pasta Boat, a 5-in-1 pasta cooker that cooks, strains, serves, steams and serves. Complete with stay-cool handles, the steamer rack can be used to steam potatoes or vegetables right in the microwave. Pasta Boat cooks pasta in approximately 18 minutes and carries a suggested retail price of $9.99;

FAIRFIELD, Calif. — Jelly Belly’s new Peas & Carrots mellowcreme mix is a whimsical, retro product that has been revived right from the company’s antique candy molds. The “baby carrots” in the mix are orange sherbet mellowcreme, while the “peas” are green apple flavor — a sweet version of a classic veggie combination.


WAYNE, N.J. — IdeaVillage’s new EasyFeet is the latest introduction in the active foot care As Seen On TV category. The flip-flop-like product — called a car wash for the feet — has 10,000 soft-scrubbing bristles and a built-in pumice stone to clean feet and rub away dead, dry skin on the heels. Suction cups hold EasyFeet in place, so consumers can safely use the product on tub and shower surfaces.


EasyFeet ships in March and will retail for $9.99. Idea­Village EVP Ronald Boger called EasyFeet a “monster hit for 2011.”

Welmedix’s First Degree therapeutic burn cream provides a unique solution for minor burns that the company suggests is an unmet need at retail. It’s an all-in-one burn cream that helps soothe pain, cool the burn, prevent infection and reduce the appearance of scars.


When ScriptPro started 
in­troducing pharmacy robots, it entered an industry where the pharmacist was mostly dolling out medications. Today, pharmacy automation and technology continue to evolve, freeing pharmacists’ time and taking on everything from workflow automation to smart-phone applications.

SUPPLIER NEWS — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores. Valeant acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.



HAYWARD, Calif. — Impax Labs received regulatory approval from the Food and Drug Administration for its generic version of a bacterial infection treatment.

The drug maker on Friday said it received final approval of its abbreviated new drug application for doxycyline monohydrate capsules in the 150-mg strength. The drug, which is a tetracycline antibiotic used to treat bacterial infections, is a generic version of Adoxa. Adoxa is manufactured by PharmDerm, a Nycomed subsidiary.

Impax said its generic division, Global Pharmaceuticals, will launch the product.